Event-Driven Stocks

WEST PHARMACEUTICAL SERVICES INC

WST

Other · Large accelerated filer · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 7 gooddetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$3.07B$2.89B$2.95B$2.89B$2.83B$2.15B
Operating income$584.9M$569.9M$676.0M$734.0M$752.3M$406.9M
Net income$493.7M$492.7M$593.4M$585.9M$661.8M$346.2M
Total assets$4.27B$3.64B$3.83B$3.62B$3.31B$2.79B
Total liabilities$1.09B$961.1M$948.5M$931.9M$978.4M$939.3M
Equity$3.18B$2.68B$2.88B$2.68B$2.34B$1.85B
EPS (diluted)$6.79$6.69$7.88$7.73$8.67$4.57
Shares out.72.3M73.3M74.1M74.3M74.1M73.8M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
19.0%
Net margin
16.1%
Return on equity
15.5%
Return on assets
11.6%
Return on capital (ROCE)
16.2%
Liabilities / assets
25.6%
Debt / equity
0.34×
Book value / share
$43.93
Revenue growth (YoY)
6.3%
Net income growth (YoY)
0.2%

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
9.34safe
Accruals / assets
−6.1%clean
Beneish M-Score
-2.79normal
Piotroski F-Score
6/9mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
87
/ 100
Profitability 100Growth 100Catalyst 33Earnings quality 100Financial strength 100

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →

Signs

● 7 good
  • Operating margin is positive
  • Strong return on equity (>15%)
  • Revenue is growing year-over-year
  • Conservative leverage (liabilities < 50% of assets)
  • Positive operating cash flow
  • Clean earnings (low accruals)
  • Altman Z″ in the safe zone

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 20262.3M2.6-5.9%
Apr 30, 20262.4M2.1-8.9%
Apr 15, 20262.7M3.6-9.0%
Mar 31, 20262.9M3.2+14.2%
Mar 13, 20262.6M2.9+8.0%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (2)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.